Valuation: Guerbet

Market Cap 114M 129M 105M 97.81M 183M 12.2B 187M 1.26B 486M 6.01B 485M 475M 20.89B P/E 2026 *
-253x
P/E 2027 * 5.59x
Enterprise Value 407M 463M 375M 351M 658M 43.73B 670M 4.5B 1.74B 21.56B 1.74B 1.7B 74.91B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.49x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.89%
1 day-1.00%
1 week-3.36%
Current month-16.73%
1 month-15.14%
3 months-7.95%
6 months-38.47%
Current year-37.69%
1 week 8.73
Extreme 8.73
9.37
1 month 8.73
Extreme 8.73
10.92
Current year 8.01
Extreme 8.01
15.12
1 year 8.01
Extreme 8.01
23.7
3 years 8.01
Extreme 8.01
40.25
5 years 8.01
Extreme 8.01
45.65
10 years 8.01
Extreme 8.01
90.64
Manager TitleAgeSince
Chief Executive Officer - 01/02/2026
Chief Executive Officer - 21/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 28/05/2015
Director/Board Member 49 18/05/2017
Director/Board Member 51 21/11/2023
Date Insider Type Main position Quantity % Market Cap.
11-12Buy

Director

90 0.0007%
11-12Buy

Director

1,100 0.0087%
09/10/25Buy

Director

200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%-3.36%-58.27%-47.40% 129M
-3.22%-5.07%-23.78%-26.57% 12.25B
-6.66%-12.39%+64.37%+9.52% 4.93B
+1.62%+3.29%+56.00%+92.53% 1.2B
-4.01%-5.67%-40.58%-66.78% 1.19B
-3.99%-11.87%-42.78%-49.47% 1.09B
-3.49%-7.80%-44.64% - 903M
-3.51%-14.31%+152.43%+159.16% 622M
+2.93%+9.49% - - 349M
+2.86%+2.29%-56.29%+209.17% 255M
Average -1.85%-3.72%+0.72%+35.02% 2.29B
Weighted average by Cap. -3.63%-5.18%+1.38%-7.12%

Financials

2026 *2027 *
Net sales 754M 858M 694M 649M 1.22B 80.97B 1.24B 8.33B 3.23B 39.92B 3.22B 3.15B 139B 796M 906M 734M 686M 1.29B 85.53B 1.31B 8.8B 3.41B 42.16B 3.4B 3.33B 147B
Net income -1.62M -1.84M -1.49M -1.39M -2.61M -174M -2.66M -17.88M -6.92M -85.63M -6.91M -6.76M -298M 29.08M 33.11M 26.79M 25.05M 46.99M 3.12B 47.85M 321M 125M 1.54B 124M 122M 5.35B
Net Debt 294M 334M 270M 253M 474M 31.53B 483M 3.24B 1.26B 15.54B 1.25B 1.23B 54.02B 277M 316M 256M 239M 448M 29.8B 456M 3.07B 1.19B 14.69B 1.19B 1.16B 51.04B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
26/06/26 8.910 -1.00% 44,462
25/06/26 €9.000 -1.96% 58,556
24/06/26 €9.180 -0.54% 8,673
23/06/26 €9.230 +1.43% 11,225
22/06/26 €9.100 -1.30% 7,788
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
9.000EUR
Average target price
11.60EUR
Spread / Average Target
+28.89%

Quarterly revenue - Rate of surprise